About this trial
The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effects on the therapy in Parkinson symptoms, we will do a set of cognitive and motor test before and after the intervention to measure any changes as well as control for any potential markers such as age, sex, disease level, medication and exercise.
Eligibility criteria
Qualifiers
Diagnosis of Parkinson disease
Disqualifiers
Participants who are unable to comply with study visit/testing requirements (e.g.
Participants who are unable to provide consent.
Participants with a Deep Brain Stimulation (DBS) device.
Participants who have a history of a psychiatric disorder
Trial design
Treatments tested in this trial
- Red Light (PDT)
- Placebo
Treatment groups
Sponsors and collaborators
University of Delaware
Lead sponsor
NeuroThera
Collaborator